Coffee and tea consumption and risk of prostate cancer in the European Prospective Investigation into Cancer and Nutrition

Abhijit Sen, Nikos Papadimitriou, Pagona Lagiou, Aurora Perez-Cornago, Ruth C. Travis, Timothy J. Key, Neil Murphy, Marc Gunter, Heinz Freisling, Ioanna Tzoulaki, David C. Muller, Amanda J. Cross, David S. Lopez, Manuela Bergmann, Heiner Boeing, Christina Bamia, Anastasia Kotanidou, Anna Karakatsani, Anne Tjønneland, Cecilie Kyrø & 27 others Malene Outzen, María Luisa Redondo, Valerie Cayssials, Maria Dolores Chirlaque, Aurelio Barricarte, Maria Jose Sánchez, Nerea Larrañaga, Rosario Tumino, Sara Grioni, Domenico Palli, Saverio Caini, Carlotta Sacerdote, Bas Bueno-de-Mesquita, Tilman Kühn, Rudolf Kaaks, Lena Maria Nilsson, Rikard Landberg, Peter Wallström, Isabel Drake, Bodil Hammer Bech, Kim Overvad, Dagfinn Aune, Kay Tee Khaw, Elio Riboli, Dimitrios Trichopoulos, Antonia Trichopoulou, Konstantinos K. Tsilidis

Research output: Contribution to journalArticle

Abstract

The epidemiological evidence regarding the association of coffee and tea consumption with prostate cancer risk is inconclusive, and few cohort studies have assessed these associations by disease stage and grade. We examined the associations of coffee (total, caffeinated and decaffeinated) and tea intake with prostate cancer risk in the European Prospective Investigation into Cancer and Nutrition. Among 142,196 men, 7,036 incident prostate cancer cases were diagnosed over 14 years of follow-up. Data on coffee and tea consumption were collected through validated country-specific food questionnaires at baseline. We used Cox proportional hazards regression models to compute hazard ratios (HRs) and 95% confidence intervals (CI). Models were stratified by center and age, and adjusted for anthropometric, lifestyle and dietary factors. Median coffee and tea intake were 375 and 106 mL/day, respectively, but large variations existed by country. Comparing the highest (median of 855 mL/day) versus lowest (median of 103 mL/day) consumers of coffee and tea (450 vs. 12 mL/day) the HRs were 1.02 (95% CI, 0.94–1.09) and 0.98 (95% CI, 0.90–1.07) for risk of total prostate cancer and 0.97 (95% CI, 0.79–1.21) and 0.89 (95% CI, 0.70–1.13) for risk of fatal disease, respectively. No evidence of association was seen for consumption of total, caffeinated or decaffeinated coffee or tea and risk of total prostate cancer or cancer by stage, grade or fatality in this large cohort. Further investigations are needed to clarify whether an association exists by different preparations or by concentrations and constituents of these beverages.

Original languageEnglish (US)
Pages (from-to)240-250
Number of pages11
JournalInternational Journal of Cancer
Volume144
Issue number2
DOIs
StatePublished - Jan 15 2019

Fingerprint

Coffee
Tea
Prostatic Neoplasms
Confidence Intervals
Neoplasms
Beverages
Proportional Hazards Models
Life Style
Cohort Studies
Food

Keywords

  • EPIC
  • caffeinated
  • coffee
  • decaffeinated
  • prostate cancer
  • tea

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Sen, A., Papadimitriou, N., Lagiou, P., Perez-Cornago, A., Travis, R. C., Key, T. J., ... Tsilidis, K. K. (2019). Coffee and tea consumption and risk of prostate cancer in the European Prospective Investigation into Cancer and Nutrition. International Journal of Cancer, 144(2), 240-250. https://doi.org/10.1002/ijc.31634

Coffee and tea consumption and risk of prostate cancer in the European Prospective Investigation into Cancer and Nutrition. / Sen, Abhijit; Papadimitriou, Nikos; Lagiou, Pagona; Perez-Cornago, Aurora; Travis, Ruth C.; Key, Timothy J.; Murphy, Neil; Gunter, Marc; Freisling, Heinz; Tzoulaki, Ioanna; Muller, David C.; Cross, Amanda J.; Lopez, David S.; Bergmann, Manuela; Boeing, Heiner; Bamia, Christina; Kotanidou, Anastasia; Karakatsani, Anna; Tjønneland, Anne; Kyrø, Cecilie; Outzen, Malene; Redondo, María Luisa; Cayssials, Valerie; Chirlaque, Maria Dolores; Barricarte, Aurelio; Sánchez, Maria Jose; Larrañaga, Nerea; Tumino, Rosario; Grioni, Sara; Palli, Domenico; Caini, Saverio; Sacerdote, Carlotta; Bueno-de-Mesquita, Bas; Kühn, Tilman; Kaaks, Rudolf; Nilsson, Lena Maria; Landberg, Rikard; Wallström, Peter; Drake, Isabel; Bech, Bodil Hammer; Overvad, Kim; Aune, Dagfinn; Khaw, Kay Tee; Riboli, Elio; Trichopoulos, Dimitrios; Trichopoulou, Antonia; Tsilidis, Konstantinos K.

In: International Journal of Cancer, Vol. 144, No. 2, 15.01.2019, p. 240-250.

Research output: Contribution to journalArticle

Sen, A, Papadimitriou, N, Lagiou, P, Perez-Cornago, A, Travis, RC, Key, TJ, Murphy, N, Gunter, M, Freisling, H, Tzoulaki, I, Muller, DC, Cross, AJ, Lopez, DS, Bergmann, M, Boeing, H, Bamia, C, Kotanidou, A, Karakatsani, A, Tjønneland, A, Kyrø, C, Outzen, M, Redondo, ML, Cayssials, V, Chirlaque, MD, Barricarte, A, Sánchez, MJ, Larrañaga, N, Tumino, R, Grioni, S, Palli, D, Caini, S, Sacerdote, C, Bueno-de-Mesquita, B, Kühn, T, Kaaks, R, Nilsson, LM, Landberg, R, Wallström, P, Drake, I, Bech, BH, Overvad, K, Aune, D, Khaw, KT, Riboli, E, Trichopoulos, D, Trichopoulou, A & Tsilidis, KK 2019, 'Coffee and tea consumption and risk of prostate cancer in the European Prospective Investigation into Cancer and Nutrition' International Journal of Cancer, vol. 144, no. 2, pp. 240-250. https://doi.org/10.1002/ijc.31634
Sen, Abhijit ; Papadimitriou, Nikos ; Lagiou, Pagona ; Perez-Cornago, Aurora ; Travis, Ruth C. ; Key, Timothy J. ; Murphy, Neil ; Gunter, Marc ; Freisling, Heinz ; Tzoulaki, Ioanna ; Muller, David C. ; Cross, Amanda J. ; Lopez, David S. ; Bergmann, Manuela ; Boeing, Heiner ; Bamia, Christina ; Kotanidou, Anastasia ; Karakatsani, Anna ; Tjønneland, Anne ; Kyrø, Cecilie ; Outzen, Malene ; Redondo, María Luisa ; Cayssials, Valerie ; Chirlaque, Maria Dolores ; Barricarte, Aurelio ; Sánchez, Maria Jose ; Larrañaga, Nerea ; Tumino, Rosario ; Grioni, Sara ; Palli, Domenico ; Caini, Saverio ; Sacerdote, Carlotta ; Bueno-de-Mesquita, Bas ; Kühn, Tilman ; Kaaks, Rudolf ; Nilsson, Lena Maria ; Landberg, Rikard ; Wallström, Peter ; Drake, Isabel ; Bech, Bodil Hammer ; Overvad, Kim ; Aune, Dagfinn ; Khaw, Kay Tee ; Riboli, Elio ; Trichopoulos, Dimitrios ; Trichopoulou, Antonia ; Tsilidis, Konstantinos K. / Coffee and tea consumption and risk of prostate cancer in the European Prospective Investigation into Cancer and Nutrition. In: International Journal of Cancer. 2019 ; Vol. 144, No. 2. pp. 240-250.
@article{09863c4d4eec44a99416639286416665,
title = "Coffee and tea consumption and risk of prostate cancer in the European Prospective Investigation into Cancer and Nutrition",
abstract = "The epidemiological evidence regarding the association of coffee and tea consumption with prostate cancer risk is inconclusive, and few cohort studies have assessed these associations by disease stage and grade. We examined the associations of coffee (total, caffeinated and decaffeinated) and tea intake with prostate cancer risk in the European Prospective Investigation into Cancer and Nutrition. Among 142,196 men, 7,036 incident prostate cancer cases were diagnosed over 14 years of follow-up. Data on coffee and tea consumption were collected through validated country-specific food questionnaires at baseline. We used Cox proportional hazards regression models to compute hazard ratios (HRs) and 95{\%} confidence intervals (CI). Models were stratified by center and age, and adjusted for anthropometric, lifestyle and dietary factors. Median coffee and tea intake were 375 and 106 mL/day, respectively, but large variations existed by country. Comparing the highest (median of 855 mL/day) versus lowest (median of 103 mL/day) consumers of coffee and tea (450 vs. 12 mL/day) the HRs were 1.02 (95{\%} CI, 0.94–1.09) and 0.98 (95{\%} CI, 0.90–1.07) for risk of total prostate cancer and 0.97 (95{\%} CI, 0.79–1.21) and 0.89 (95{\%} CI, 0.70–1.13) for risk of fatal disease, respectively. No evidence of association was seen for consumption of total, caffeinated or decaffeinated coffee or tea and risk of total prostate cancer or cancer by stage, grade or fatality in this large cohort. Further investigations are needed to clarify whether an association exists by different preparations or by concentrations and constituents of these beverages.",
keywords = "EPIC, caffeinated, coffee, decaffeinated, prostate cancer, tea",
author = "Abhijit Sen and Nikos Papadimitriou and Pagona Lagiou and Aurora Perez-Cornago and Travis, {Ruth C.} and Key, {Timothy J.} and Neil Murphy and Marc Gunter and Heinz Freisling and Ioanna Tzoulaki and Muller, {David C.} and Cross, {Amanda J.} and Lopez, {David S.} and Manuela Bergmann and Heiner Boeing and Christina Bamia and Anastasia Kotanidou and Anna Karakatsani and Anne Tj{\o}nneland and Cecilie Kyr{\o} and Malene Outzen and Redondo, {Mar{\'i}a Luisa} and Valerie Cayssials and Chirlaque, {Maria Dolores} and Aurelio Barricarte and S{\'a}nchez, {Maria Jose} and Nerea Larra{\~n}aga and Rosario Tumino and Sara Grioni and Domenico Palli and Saverio Caini and Carlotta Sacerdote and Bas Bueno-de-Mesquita and Tilman K{\"u}hn and Rudolf Kaaks and Nilsson, {Lena Maria} and Rikard Landberg and Peter Wallstr{\"o}m and Isabel Drake and Bech, {Bodil Hammer} and Kim Overvad and Dagfinn Aune and Khaw, {Kay Tee} and Elio Riboli and Dimitrios Trichopoulos and Antonia Trichopoulou and Tsilidis, {Konstantinos K.}",
year = "2019",
month = "1",
day = "15",
doi = "10.1002/ijc.31634",
language = "English (US)",
volume = "144",
pages = "240--250",
journal = "International Journal of Cancer",
issn = "0020-7136",
publisher = "Wiley-Liss Inc.",
number = "2",

}

TY - JOUR

T1 - Coffee and tea consumption and risk of prostate cancer in the European Prospective Investigation into Cancer and Nutrition

AU - Sen, Abhijit

AU - Papadimitriou, Nikos

AU - Lagiou, Pagona

AU - Perez-Cornago, Aurora

AU - Travis, Ruth C.

AU - Key, Timothy J.

AU - Murphy, Neil

AU - Gunter, Marc

AU - Freisling, Heinz

AU - Tzoulaki, Ioanna

AU - Muller, David C.

AU - Cross, Amanda J.

AU - Lopez, David S.

AU - Bergmann, Manuela

AU - Boeing, Heiner

AU - Bamia, Christina

AU - Kotanidou, Anastasia

AU - Karakatsani, Anna

AU - Tjønneland, Anne

AU - Kyrø, Cecilie

AU - Outzen, Malene

AU - Redondo, María Luisa

AU - Cayssials, Valerie

AU - Chirlaque, Maria Dolores

AU - Barricarte, Aurelio

AU - Sánchez, Maria Jose

AU - Larrañaga, Nerea

AU - Tumino, Rosario

AU - Grioni, Sara

AU - Palli, Domenico

AU - Caini, Saverio

AU - Sacerdote, Carlotta

AU - Bueno-de-Mesquita, Bas

AU - Kühn, Tilman

AU - Kaaks, Rudolf

AU - Nilsson, Lena Maria

AU - Landberg, Rikard

AU - Wallström, Peter

AU - Drake, Isabel

AU - Bech, Bodil Hammer

AU - Overvad, Kim

AU - Aune, Dagfinn

AU - Khaw, Kay Tee

AU - Riboli, Elio

AU - Trichopoulos, Dimitrios

AU - Trichopoulou, Antonia

AU - Tsilidis, Konstantinos K.

PY - 2019/1/15

Y1 - 2019/1/15

N2 - The epidemiological evidence regarding the association of coffee and tea consumption with prostate cancer risk is inconclusive, and few cohort studies have assessed these associations by disease stage and grade. We examined the associations of coffee (total, caffeinated and decaffeinated) and tea intake with prostate cancer risk in the European Prospective Investigation into Cancer and Nutrition. Among 142,196 men, 7,036 incident prostate cancer cases were diagnosed over 14 years of follow-up. Data on coffee and tea consumption were collected through validated country-specific food questionnaires at baseline. We used Cox proportional hazards regression models to compute hazard ratios (HRs) and 95% confidence intervals (CI). Models were stratified by center and age, and adjusted for anthropometric, lifestyle and dietary factors. Median coffee and tea intake were 375 and 106 mL/day, respectively, but large variations existed by country. Comparing the highest (median of 855 mL/day) versus lowest (median of 103 mL/day) consumers of coffee and tea (450 vs. 12 mL/day) the HRs were 1.02 (95% CI, 0.94–1.09) and 0.98 (95% CI, 0.90–1.07) for risk of total prostate cancer and 0.97 (95% CI, 0.79–1.21) and 0.89 (95% CI, 0.70–1.13) for risk of fatal disease, respectively. No evidence of association was seen for consumption of total, caffeinated or decaffeinated coffee or tea and risk of total prostate cancer or cancer by stage, grade or fatality in this large cohort. Further investigations are needed to clarify whether an association exists by different preparations or by concentrations and constituents of these beverages.

AB - The epidemiological evidence regarding the association of coffee and tea consumption with prostate cancer risk is inconclusive, and few cohort studies have assessed these associations by disease stage and grade. We examined the associations of coffee (total, caffeinated and decaffeinated) and tea intake with prostate cancer risk in the European Prospective Investigation into Cancer and Nutrition. Among 142,196 men, 7,036 incident prostate cancer cases were diagnosed over 14 years of follow-up. Data on coffee and tea consumption were collected through validated country-specific food questionnaires at baseline. We used Cox proportional hazards regression models to compute hazard ratios (HRs) and 95% confidence intervals (CI). Models were stratified by center and age, and adjusted for anthropometric, lifestyle and dietary factors. Median coffee and tea intake were 375 and 106 mL/day, respectively, but large variations existed by country. Comparing the highest (median of 855 mL/day) versus lowest (median of 103 mL/day) consumers of coffee and tea (450 vs. 12 mL/day) the HRs were 1.02 (95% CI, 0.94–1.09) and 0.98 (95% CI, 0.90–1.07) for risk of total prostate cancer and 0.97 (95% CI, 0.79–1.21) and 0.89 (95% CI, 0.70–1.13) for risk of fatal disease, respectively. No evidence of association was seen for consumption of total, caffeinated or decaffeinated coffee or tea and risk of total prostate cancer or cancer by stage, grade or fatality in this large cohort. Further investigations are needed to clarify whether an association exists by different preparations or by concentrations and constituents of these beverages.

KW - EPIC

KW - caffeinated

KW - coffee

KW - decaffeinated

KW - prostate cancer

KW - tea

UR - http://www.scopus.com/inward/record.url?scp=85056735946&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85056735946&partnerID=8YFLogxK

U2 - 10.1002/ijc.31634

DO - 10.1002/ijc.31634

M3 - Article

VL - 144

SP - 240

EP - 250

JO - International Journal of Cancer

JF - International Journal of Cancer

SN - 0020-7136

IS - 2

ER -